Medicare Enrolled
Dr. Vasantha Perkari, MD
Internal Medicine · Matawan, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perkari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perkari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perkari
Dr. Vasantha Perkari is an internal medicine specialist in Matawan, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Perkari performed 4,622 Medicare services across 2,857 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perkari received a total of $5,580 from 47 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perkari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in NJ
$5,580 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,622
Medicare services
Top 6% in NJ for internal medicine
2,857
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,258 | $70 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
788 | $100 | $172 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
480 | $67 | $125 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
460 | $140 | $195 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
178 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
173 | $72 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $45 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
134 | $9 | $55 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
101 | $78 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
97 | $111 | $250 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
96 | $64 | $95 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
89 | $114 | $185 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
79 | $101 | $175 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
73 | $98 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
72 | $11 | $33 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $113 | $190 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 58 | $68 | $140 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
48 | $91 | $125 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
37 | $179 | $250 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
35 | $240 | $350 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
32 | $179 | $250 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
25 | $178 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $147 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $126 | $175 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $33 | $95 |
| New patient office visit, complex (60-74 min) | 12 | $71 | $231 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
11 | $11 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,580
Total received (2018-2024)
Avg $797/year across 7 years
Top 14% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,580 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$157
2023
$260
2022
$540
2021
$958
2020
$1,191
2019
$1,077
2018
$1,397
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$52
ABBVIE INC.
$28
Dexcom, Inc.
$28
Abbott Laboratories
$21
Astellas Pharma US Inc
$15
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 68.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$812
Novo Nordisk Inc
$681
PFIZER INC.
$422
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$285
AstraZeneca Pharmaceuticals LP
$245
AbbVie Inc.
$242
ABBVIE INC.
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
Merck Sharp & Dohme Corporation
$219
Amgen Inc.
$199
Sunovion Pharmaceuticals Inc.
$195
SANOFI-AVENTIS U.S. LLC
$173
Horizon Therapeutics plc
$159
Lilly USA, LLC
$159
Abbott Laboratories
$132
GlaxoSmithKline, LLC.
$129
Astellas Pharma US Inc
$82
Biohaven Pharmaceutical Holding Company Ltd.
$79
Novartis Pharmaceuticals Corporation
$77
Kowa Pharmaceuticals America, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$71
ARBOR PHARMACEUTICALS, INC.
$65
Avanir Pharmaceuticals, Inc.
$54
Esperion Therapeutics, Inc.
$53
Bausch Health US, LLC
$45
Eisai Inc.
$43
ACADIA Pharmaceuticals Inc
$42
Allergan Inc.
$42
Teva Pharmaceuticals USA, Inc.
$38
Dexcom, Inc.
$28
Mylan Specialty L.P.
$25
Horizon Pharma plc
$24
Bayer HealthCare Pharmaceuticals Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Supernus Pharmaceuticals, Inc.
$17
AbbVie, Inc.
$15
Almatica Pharma LLC
$15
UCB, Inc.
$14
Philips Electronics North America Corporation
$14
Lundbeck LLC
$14
Circassia Pharmaceuticals Inc
$14
Biohaven Pharmaceuticals, Inc.
$13
Amarin Pharma Inc.
$13
Radius Health, Inc.
$13
Agile Therapeutics, Inc.
$12
Allergan, Inc.
$12
IBSA Pharma Inc.
$11
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AJOVY · APLENZIN · APTIOM · AREXVY · Aimovig · BELSOMRA · BENLYSTA · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Creon · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · Horizant · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LATUDA · LEQVIO · LINZESS · LONHALA MAGNAIR · LOREEV XR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Otezla · Ozempic · PENNSAID · PREMARIN · PROCLAIM · Proclaim IPG · Prolia · QULIPTA · RAYOS · REXULTI · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLUJAN · STIOLTO RESPIMAT · SYNTHROID · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULANCE · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · Twirla · Tymlos · UBRELVY · Utibron · VIAGRA · VIMOVO · VRAYLAR · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · Xultophy 100/3.6 · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
3,789
Per 100K population
439.8
County median income
$109,028
Nearest hospital
BAYSHORE MEDICAL CENTER
5.1 mi
5.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perkari is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement in the top 14% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perkari experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Perkari performed 1,258 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perkari receive payments from pharmaceutical companies?
Yes. Dr. Perkari received a total of $5,580 from 47 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perkari's costs compare to other internal medicine physicians in Matawan?
Dr. Perkari's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perkari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Matawan
Browse internal medicine physicians in Matawan ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology